Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin

OBJECTIVE—We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile. METHODS AND RESULTS—By the search of DNA sequences in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2006-05, Vol.26 (5), p.1051-1057
Hauptverfasser: Shibuya, Takumi, Watanabe, Kazuhide, Yamashita, Hiroshi, Shimizu, Kazue, Miyashita, Hiroki, Abe, Mayumi, Moriya, Takuya, Ohta, Hideki, Sonoda, Hikaru, Shimosegawa, Tooru, Tabayashi, Koichi, Sato, Yasufumi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1057
container_issue 5
container_start_page 1051
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 26
creator Shibuya, Takumi
Watanabe, Kazuhide
Yamashita, Hiroshi
Shimizu, Kazue
Miyashita, Hiroki
Abe, Mayumi
Moriya, Takuya
Ohta, Hideki
Sonoda, Hikaru
Shimosegawa, Tooru
Tabayashi, Koichi
Sato, Yasufumi
description OBJECTIVE—We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile. METHODS AND RESULTS—By the search of DNA sequences in the database, we found one homologous gene and designated it vasohibin-2. Overall amino acid sequence homology between the prototype vasohibin (vasohibin-1) and vasohibin-2 was >50%. Vasohibin-2 exhibited antiangiogenic activity. Vasohibin-2 expression in cultured endothelial cells was low and not inducible by the stimulation that induced vasohibin-1. However, the immunohistochemical analysis revealed that vasohibin-1 and -2 were diffusely expressed in endothelial cells in embryonic organs during mid-gestation. After that time point, vasohibin-1 and -2 became faint, but persisted to a certain extent in arterial endothelial cells from late gestation to neonate. Expression of vasohibin-1 and -2 could be augmented in vivo by local transfection with the VEGF gene in the embryonic brain or by cutaneous wounding in adult mice. CONCLUSION—These results suggest that vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.
doi_str_mv 10.1161/01.ATV.0000216747.66660.26
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67877677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67877677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5447-e425ba4b9c6cb7256427caf7062a8ea4d25f1f5d08c66632f5a242b11821edf03</originalsourceid><addsrcrecordid>eNpFkU1v3CAQhq2qVfPR_oUKVWpvuDDmw-lttd0kK0XqJc0VYYzXtBhSsBu11_7xsNmVdiTEAM-8I-atqo-U1JQK-oXQenX_UJMSQIVkshYlSA3iVXVOOTDMRCNel5zIK8wFg7PqIuefhWcA5G11RgWHlhBxXv3f5uj17GJAOvRoPeqkzWyT-3e4jAN60DmOrnMBA9IZaXQbp-jjbrEvr5uba7wN_WJc5y3ahD7Oo_VumfC3IvPH9mgVdi7ubLDZZbQNe605ppPuu-rNoH2274_7ZfXjenO_vsV332-269UdNpwxiS0D3mnWXRlhOgn7f0mjB0kE6NZq1gMf6MB70poyjgYGroFBR2kL1PYDaS6rzwfdxxR_LzbPanLZWO91sHHJSshWSiFlAb8eQJNizskO6jG5Sae_ihK1t0ARqooF6mSBerFAgSjFH45dlm6y_an0OPMCfDoCOhvth6SDcfnESUkbIG3h2IF7ir44kn_55ckmNVrt53HfmjWCcAxFk_ByxGVR2TwDS8Cf-g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67877677</pqid></control><display><type>article</type><title>Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Shibuya, Takumi ; Watanabe, Kazuhide ; Yamashita, Hiroshi ; Shimizu, Kazue ; Miyashita, Hiroki ; Abe, Mayumi ; Moriya, Takuya ; Ohta, Hideki ; Sonoda, Hikaru ; Shimosegawa, Tooru ; Tabayashi, Koichi ; Sato, Yasufumi</creator><creatorcontrib>Shibuya, Takumi ; Watanabe, Kazuhide ; Yamashita, Hiroshi ; Shimizu, Kazue ; Miyashita, Hiroki ; Abe, Mayumi ; Moriya, Takuya ; Ohta, Hideki ; Sonoda, Hikaru ; Shimosegawa, Tooru ; Tabayashi, Koichi ; Sato, Yasufumi</creatorcontrib><description>OBJECTIVE—We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile. METHODS AND RESULTS—By the search of DNA sequences in the database, we found one homologous gene and designated it vasohibin-2. Overall amino acid sequence homology between the prototype vasohibin (vasohibin-1) and vasohibin-2 was &gt;50%. Vasohibin-2 exhibited antiangiogenic activity. Vasohibin-2 expression in cultured endothelial cells was low and not inducible by the stimulation that induced vasohibin-1. However, the immunohistochemical analysis revealed that vasohibin-1 and -2 were diffusely expressed in endothelial cells in embryonic organs during mid-gestation. After that time point, vasohibin-1 and -2 became faint, but persisted to a certain extent in arterial endothelial cells from late gestation to neonate. Expression of vasohibin-1 and -2 could be augmented in vivo by local transfection with the VEGF gene in the embryonic brain or by cutaneous wounding in adult mice. CONCLUSION—These results suggest that vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/01.ATV.0000216747.66660.26</identifier><identifier>PMID: 16528006</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiogenesis Inhibitors - analysis ; Angiogenesis Inhibitors - genetics ; Angiogenesis Inhibitors - pharmacology ; Animals ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Cells, Cultured ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Endothelial Cells - chemistry ; Humans ; Immunohistochemistry ; Investigative techniques of hemodynamics ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Mice ; Neovascularization, Physiologic - drug effects ; Organ Culture Techniques ; Pharmacology. Drug treatments ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - analysis ; Vasodilator agents. Cerebral vasodilators</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2006-05, Vol.26 (5), p.1051-1057</ispartof><rights>2006 American Heart Association, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5447-e425ba4b9c6cb7256427caf7062a8ea4d25f1f5d08c66632f5a242b11821edf03</citedby><cites>FETCH-LOGICAL-c5447-e425ba4b9c6cb7256427caf7062a8ea4d25f1f5d08c66632f5a242b11821edf03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17713208$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16528006$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibuya, Takumi</creatorcontrib><creatorcontrib>Watanabe, Kazuhide</creatorcontrib><creatorcontrib>Yamashita, Hiroshi</creatorcontrib><creatorcontrib>Shimizu, Kazue</creatorcontrib><creatorcontrib>Miyashita, Hiroki</creatorcontrib><creatorcontrib>Abe, Mayumi</creatorcontrib><creatorcontrib>Moriya, Takuya</creatorcontrib><creatorcontrib>Ohta, Hideki</creatorcontrib><creatorcontrib>Sonoda, Hikaru</creatorcontrib><creatorcontrib>Shimosegawa, Tooru</creatorcontrib><creatorcontrib>Tabayashi, Koichi</creatorcontrib><creatorcontrib>Sato, Yasufumi</creatorcontrib><title>Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile. METHODS AND RESULTS—By the search of DNA sequences in the database, we found one homologous gene and designated it vasohibin-2. Overall amino acid sequence homology between the prototype vasohibin (vasohibin-1) and vasohibin-2 was &gt;50%. Vasohibin-2 exhibited antiangiogenic activity. Vasohibin-2 expression in cultured endothelial cells was low and not inducible by the stimulation that induced vasohibin-1. However, the immunohistochemical analysis revealed that vasohibin-1 and -2 were diffusely expressed in endothelial cells in embryonic organs during mid-gestation. After that time point, vasohibin-1 and -2 became faint, but persisted to a certain extent in arterial endothelial cells from late gestation to neonate. Expression of vasohibin-1 and -2 could be augmented in vivo by local transfection with the VEGF gene in the embryonic brain or by cutaneous wounding in adult mice. CONCLUSION—These results suggest that vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.</description><subject>Angiogenesis Inhibitors - analysis</subject><subject>Angiogenesis Inhibitors - genetics</subject><subject>Angiogenesis Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Cells, Cultured</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Endothelial Cells - chemistry</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Investigative techniques of hemodynamics</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Organ Culture Techniques</subject><subject>Pharmacology. Drug treatments</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - analysis</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1v3CAQhq2qVfPR_oUKVWpvuDDmw-lttd0kK0XqJc0VYYzXtBhSsBu11_7xsNmVdiTEAM-8I-atqo-U1JQK-oXQenX_UJMSQIVkshYlSA3iVXVOOTDMRCNel5zIK8wFg7PqIuefhWcA5G11RgWHlhBxXv3f5uj17GJAOvRoPeqkzWyT-3e4jAN60DmOrnMBA9IZaXQbp-jjbrEvr5uba7wN_WJc5y3ahD7Oo_VumfC3IvPH9mgVdi7ubLDZZbQNe605ppPuu-rNoH2274_7ZfXjenO_vsV332-269UdNpwxiS0D3mnWXRlhOgn7f0mjB0kE6NZq1gMf6MB70poyjgYGroFBR2kL1PYDaS6rzwfdxxR_LzbPanLZWO91sHHJSshWSiFlAb8eQJNizskO6jG5Sae_ihK1t0ARqooF6mSBerFAgSjFH45dlm6y_an0OPMCfDoCOhvth6SDcfnESUkbIG3h2IF7ir44kn_55ckmNVrt53HfmjWCcAxFk_ByxGVR2TwDS8Cf-g</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Shibuya, Takumi</creator><creator>Watanabe, Kazuhide</creator><creator>Yamashita, Hiroshi</creator><creator>Shimizu, Kazue</creator><creator>Miyashita, Hiroki</creator><creator>Abe, Mayumi</creator><creator>Moriya, Takuya</creator><creator>Ohta, Hideki</creator><creator>Sonoda, Hikaru</creator><creator>Shimosegawa, Tooru</creator><creator>Tabayashi, Koichi</creator><creator>Sato, Yasufumi</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200605</creationdate><title>Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin</title><author>Shibuya, Takumi ; Watanabe, Kazuhide ; Yamashita, Hiroshi ; Shimizu, Kazue ; Miyashita, Hiroki ; Abe, Mayumi ; Moriya, Takuya ; Ohta, Hideki ; Sonoda, Hikaru ; Shimosegawa, Tooru ; Tabayashi, Koichi ; Sato, Yasufumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5447-e425ba4b9c6cb7256427caf7062a8ea4d25f1f5d08c66632f5a242b11821edf03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Angiogenesis Inhibitors - analysis</topic><topic>Angiogenesis Inhibitors - genetics</topic><topic>Angiogenesis Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Cells, Cultured</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Endothelial Cells - chemistry</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Investigative techniques of hemodynamics</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Organ Culture Techniques</topic><topic>Pharmacology. Drug treatments</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - analysis</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibuya, Takumi</creatorcontrib><creatorcontrib>Watanabe, Kazuhide</creatorcontrib><creatorcontrib>Yamashita, Hiroshi</creatorcontrib><creatorcontrib>Shimizu, Kazue</creatorcontrib><creatorcontrib>Miyashita, Hiroki</creatorcontrib><creatorcontrib>Abe, Mayumi</creatorcontrib><creatorcontrib>Moriya, Takuya</creatorcontrib><creatorcontrib>Ohta, Hideki</creatorcontrib><creatorcontrib>Sonoda, Hikaru</creatorcontrib><creatorcontrib>Shimosegawa, Tooru</creatorcontrib><creatorcontrib>Tabayashi, Koichi</creatorcontrib><creatorcontrib>Sato, Yasufumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibuya, Takumi</au><au>Watanabe, Kazuhide</au><au>Yamashita, Hiroshi</au><au>Shimizu, Kazue</au><au>Miyashita, Hiroki</au><au>Abe, Mayumi</au><au>Moriya, Takuya</au><au>Ohta, Hideki</au><au>Sonoda, Hikaru</au><au>Shimosegawa, Tooru</au><au>Tabayashi, Koichi</au><au>Sato, Yasufumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2006-05</date><risdate>2006</risdate><volume>26</volume><issue>5</issue><spage>1051</spage><epage>1057</epage><pages>1051-1057</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile. METHODS AND RESULTS—By the search of DNA sequences in the database, we found one homologous gene and designated it vasohibin-2. Overall amino acid sequence homology between the prototype vasohibin (vasohibin-1) and vasohibin-2 was &gt;50%. Vasohibin-2 exhibited antiangiogenic activity. Vasohibin-2 expression in cultured endothelial cells was low and not inducible by the stimulation that induced vasohibin-1. However, the immunohistochemical analysis revealed that vasohibin-1 and -2 were diffusely expressed in endothelial cells in embryonic organs during mid-gestation. After that time point, vasohibin-1 and -2 became faint, but persisted to a certain extent in arterial endothelial cells from late gestation to neonate. Expression of vasohibin-1 and -2 could be augmented in vivo by local transfection with the VEGF gene in the embryonic brain or by cutaneous wounding in adult mice. CONCLUSION—These results suggest that vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>16528006</pmid><doi>10.1161/01.ATV.0000216747.66660.26</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2006-05, Vol.26 (5), p.1051-1057
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_67877677
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Angiogenesis Inhibitors - analysis
Angiogenesis Inhibitors - genetics
Angiogenesis Inhibitors - pharmacology
Animals
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular system
Cells, Cultured
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Endothelial Cells - chemistry
Humans
Immunohistochemistry
Investigative techniques of hemodynamics
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Mice
Neovascularization, Physiologic - drug effects
Organ Culture Techniques
Pharmacology. Drug treatments
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - analysis
Vasodilator agents. Cerebral vasodilators
title Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A49%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolation%20and%20Characterization%20of%20Vasohibin-2%20as%20a%20Homologue%20of%20VEGF-Inducible%20Endothelium-Derived%20Angiogenesis%20Inhibitor%20Vasohibin&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Shibuya,%20Takumi&rft.date=2006-05&rft.volume=26&rft.issue=5&rft.spage=1051&rft.epage=1057&rft.pages=1051-1057&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/01.ATV.0000216747.66660.26&rft_dat=%3Cproquest_cross%3E67877677%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67877677&rft_id=info:pmid/16528006&rfr_iscdi=true